title: Consistency and standardization of color in medical imaging: a consensus report.
abstract: This article summarizes the consensus reached at the Summit on Color in Medical Imaging held at the Food and Drug Administration (FDA) on May 8-9, 2013, co-sponsored by the FDA and ICC (International Color Consortium). The purpose of the meeting was to gather information on how color is currently handled by medical imaging systems to identify areas where there is a need for improvement, to define objective requirements, and to facilitate consensus development of best practices. Participants were asked to identify areas of concern and unmet needs. This summary documents the topics that were discussed at the meeting and recommendations that were made by the participants. Key areas identified where improvements in color would provide immediate tangible benefits were those of digital microscopy, telemedicine, medical photography (particularly ophthalmic and dental photography), and display calibration. Work in these and other related areas has been started within several professional groups, including the creation of the ICC Medical Imaging Working Group.
authors.affiliation: Division of Imaging and Applied Mathematics, Center for Devices and Radiological Health, U.S. Food and Drug Administration, 10993 New Hampshire Ave., 20993, Silver Spring, USA, aldo.badano@fda.hhs.gov.
authors.forename: Aldo
authors.initials: A
authors.lastname: Badano
authors.forename: Craig
authors.initials: C
authors.lastname: Revie
authors.forename: Andrew
authors.initials: A
authors.lastname: Casertano
authors.forename: Wei-Chung
authors.initials: WC
authors.lastname: Cheng
authors.forename: Phil
authors.initials: P
authors.lastname: Green
authors.forename: Tom
authors.initials: T
authors.lastname: Kimpe
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Krupinski
authors.forename: Christye
authors.initials: C
authors.lastname: Sisson
authors.forename: Stein
authors.initials: S
authors.lastname: Skrøvseth
authors.forename: Darren
authors.initials: D
authors.lastname: Treanor
authors.forename: Paul
authors.initials: P
authors.lastname: Boynton
authors.forename: David
authors.initials: D
authors.lastname: Clunie
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Flynn
authors.forename: Tatsuo
authors.initials: T
authors.lastname: Heki
authors.forename: Stephen
authors.initials: S
authors.lastname: Hewitt
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Homma
authors.forename: Andy
authors.initials: A
authors.lastname: Masia
authors.forename: Takashi
authors.initials: T
authors.lastname: Matsui
authors.forename: Balázs
authors.initials: B
authors.lastname: Nagy
authors.forename: Masahiro
authors.initials: M
authors.lastname: Nishibori
authors.forename: John
authors.initials: J
authors.lastname: Penczek
authors.forename: Thomas
authors.initials: T
authors.lastname: Schopf
authors.forename: Yukako
authors.initials: Y
authors.lastname: Yagi
authors.forename: Hideto
authors.initials: H
authors.lastname: Yokoi
mesh_terms: D003116:Color / Q000592:standards*; D003952:Diagnostic Imaging / Q000592:standards*; D006801:Humans; D012015:Reference Standards; D014481:United States; D014486:United States Food and Drug Administration